Anaphylaxis following quadrivalent human papillomavirus vaccination Read more about Anaphylaxis following quadrivalent human papillomavirus vaccination27 views
Monitoring vaccine safety: a critical component of every immunisation program [editorial] Read more about Monitoring vaccine safety: a critical component of every immunisation program [editorial] 23 views
Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2007 Read more about Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 20073 views
Annual report on surveillance of adverse events following immunisation in Australia, 2006 Read more about Annual report on surveillance of adverse events following immunisation in Australia, 20069 views
Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: a randomised controlled trial Read more about Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: a randomised controlled trial64 views
Supplementary report: surveillance of adverse events following immunisation among children aged <7 years in Australia, 1 January to 30 June 2006 Read more about Supplementary report: surveillance of adverse events following immunisation among children aged 3 views
Unexplained cases of sudden infant death shortly after hexavalent vaccination [letter] Read more about Unexplained cases of sudden infant death shortly after hexavalent vaccination [letter] 58 views
Annual report: surveillance of adverse events following immunisation in Australia, 2005 Read more about Annual report: surveillance of adverse events following immunisation in Australia, 20056 views
Monitoring vaccine reactions in Australia [editorial]. Read more about Monitoring vaccine reactions in Australia [editorial]. 7 views
When science is not enough – a risk/benefit profile of thiomersal-containing vaccines Read more about When science is not enough – a risk/benefit profile of thiomersal-containing vaccines 57 views
